托芬度与患心血管疾病的风险之间的关联:系统性审查和元分析
Jing Zhang1, Xia Jiang2, Bo Pang2
1Department of General Surgery, Department of Vascular Surgery, The First Hospital of Hebei Medical University, Shijiazhuang, China.
Nutrition & metabolism
|October 15, 2024
概括
较低的托芬水平与心血管疾病 (CVD) 风险增加有关. 监测和可能干预托水平可能有助于预防心脏病.
科学领域:
- 生物化学 生物化学
- 心脏病学 心脏病学
- 营养科学 营养科学
背景情况:
- 氨基酸的代谢调节已被认为是预防心血管疾病 (CVD).
- 在心血管疾病风险中,必需氨基酸托芬在心血管疾病风险中的特定作用仍然不完全理解.
研究的目的:
- 系统地审查和分析有关托水平与心血管疾病风险之间的联系的现有证据.
- 阐明托芬对心血管疾病发展的影响.
主要方法:
- 在主要数据库 (PubMed,Embase,Web of Science,Cochrane Library,CNKI) 进行全面的文献搜索,截至2024年8月.
- 来自13项研究 (34,370名参与者) 的数据的元分析,包括队列和病例对照设计.
- 进行了子组和灵敏度分析,以确保聚合效应估计的可靠性.
主要成果:
- 与健康个体相比,患有心血管疾病的患者的血三甲水平明显较低 (SMD = -8.57,P = 0.02).
- 循环托芬水平的降低与心血管事件的风险增加有关 (HR = 0.85,P < 0.00001).
- 包括心血管疾病包括冠状动脉疾病,心力衰竭和外周动脉疾病.
结论:
- 循环托芬水平降低是心血管疾病风险增加的重要指标.
- 调节托芬水平为心血管疾病预防策略提供了潜在的治疗目标.
相关概念视频
Psychoneuroimmunology: Cardiovascular Disease
25
Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
A key area of focus in PNI is the relationship between stress and coronary...
25
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
61
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
61
Coronary Artery Disease I: Introduction
3
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
3
Increased pulse rate
649
Tachycardia is a condition marked by an abnormally fast or irregular heart rate, surpassing the typical resting rate. In adults, tachycardia is characterized by a pulse rate ranging from 100 to 180 beats per minute. The increased heart rate can result in inadequate blood flow to various body parts, ultimately diminishing the oxygen supply to organs and tissues.
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...
649
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
47
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
47
Assessment of the Cardiovascular System I: Subjective Data
282
A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
282

![Radiosynthesis of 1-2-[18F]Fluoroethyl-L-Tryptophan using a One-pot, Two-step Protocol](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F63025.jpg&w=3840&q=50)
